Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Silver ions (Ag⁺) are broad-spectrum antimicrobial agents that target multiple molecular and cellular components in bacteria, fungi, and some viruses. They exert their antimicrobial effects through several mechanisms, including interaction with thiol groups of proteins and enzymes, disruption of cell membranes, inhibition of DNA replication, interference with ribosomes, generation of reactive oxygen species, and biofilm disruption. This multifaceted action means it is effective against a wide range of microorganisms, including multi-resistant strains.
Multiple mechanisms: binding to thiol groups in proteins, disrupting cell membranes, inhibiting DNA replication, interfering with ribosomes, generating reactive oxygen species, and disrupting biofilms.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Silver Ions (Ag⁺).